Tag: Peripheral iv

Extravasation, the leakage of a vesicant drug into surrounding tissue, can cause severe and irreversible local injuries. For this reason, when administering a vesicant drug by short-term infusion through a peripheral vein, strict safety protocols including frequent blood return verification are essential to mitigate risk.

An estimated 500 to 1,000 new cases of Pulmonary Arterial Hypertension (PAH) are diagnosed in the U.S. each year, a rare condition often managed with continuous medication [1.6.1, 1.6.5]. For patients on Remodulin (treprostinil), a critical question arises: **Can Remodulin be given peripherally?** While possible, it's reserved for temporary, short-term situations [1.2.1].

According to the American Cancer Society, the three main IV access methods are peripheral IVs, midline catheters, and central venous catheters. The choice among these options is a critical medical decision, tailored to a patient's treatment plan, the type of medication, and the anticipated duration of therapy.

Over one billion peripheral venous catheters (PVCs) are used annually worldwide, making insertion one of the most common invasive procedures in healthcare. A peripheral venous catheter is a small, flexible tube placed into a superficial vein, typically in the arm or hand, to provide temporary access to the bloodstream.